Raymond James Financial Services Advisors, Inc. Biomarin Pharmaceutical Inc Put Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Put Options

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q3 2017 Oct 26, 2017	SELL	$80.6 - $94.95 $1.09 Million - $1.28 Million	-13,500 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	13,500	13,500 $9,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.53 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.3 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.27 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$936 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$707 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account